Clinical Trials
15 trialsNCT04091295 2026-03-04
BLESSED: Expanded Access for DNG64-CAR-V for Advanced Pancreatic Cancer, Sarcoma and Carcinoma of Breast
Aveni Foundation
Available
NCT05064306 2025-08-01
131I-omburtamab for the Treatment of Central Nervous System/Leptomeningeal Neoplasms in Children and Young Adults
Memorial Sloan Kettering Cancer Center
No longer available
NCT03493152 2025-05-28
Expanded Access to Everolimus, for an Individual Patient With GIST (Gastrointestinal Stromal Tumors)(CTMS#18-0019)
The University of Texas Health Science Center at San Antonio
No longer available
NCT00906984 2024-01-08
TheraSphere
University of California, Irvine
Approved for marketing
NCT02960620 2022-09-28
Therasphere for Unresectable Primary or Secondary Liver Neoplasia
H. Lee Moffitt Cancer Center and Research Institute
No longer available
NCT02449135 2021-09-09
Nano Drug Interventional Therapy Using Digital Subtraction Angiography（DSA） for Pancreatic Carcinoma
Fuda Cancer Hospital, Guangzhou
No longer available
NCT01076517 2021-04-01
A Humanitarian Device Exemption Treatment Protocol of TheraSphere For Treatment of Unresectable Hepatocellular Carcinoma
Stanford University
Approved for marketing
NCT01480128 2020-06-19
SIMPLE
The Catholic University of Korea
Approved for marketing
NCT02436044 2019-08-20
HAIC Using Oxaliplatin Plus Fluorouracil/Leucovorin for Patients With Locally Advanced HCC
Sun Yat-sen University
Approved for marketing
NCT02564224 2018-06-06
PURSE
Zhejiang University
No longer available
NCT00701168 2017-08-23
Therasphere® for Treatment of Unresectable Primary Liver Cancer and Metastatic Liver Cancer
Leo W. Jenkins Cancer Center
No longer available
NCT00589030 2017-02-15
Yttrium Y 90 Radiolabeled Glass Beads in Treating Patients With Liver Cancer That Cannot Be Removed by Surgery
City of Hope Medical Center
No longer available
NCT02082691 2014-03-10
Continued Administration of G-202 for One Patient With Advanced Hepatocellular Carcinoma
The University of Texas Health Science Center at San Antonio
No longer available
NCT01267461 2012-08-10
Evaluation of the Proliferative Activities of Insulin Analogues in Primary Human Tumor Cells
Meir Medical Center
Available
NCT00786058 2009-06-15
A Phase III Second Line Trial in Advanced Pancreatic Cancer CONKO 003
CONKO-Studiengruppe
Approved for marketing